American International Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-418,331
Closed -$6.18M 2227
2024
Q1
$6.18M Sell
418,331
-7,241
-2% -$100K 0.02% 652
2023
Q4
$6.07M Sell
425,572
-13,854
-3% -$197K 0.03% 642
2023
Q3
$6.13M Sell
439,426
-18,730
-4% -$240K 0.04% 590
2023
Q2
$5.39M Sell
458,156
-7,333
-2% -$83.5K 0.03% 691
2023
Q1
$5.35M Sell
465,489
-1,070
-0.2% -$13.2K 0.04% 676
2022
Q4
$5.8M Sell
466,559
-5,101
-1% -$65K 0.04% 636
2022
Q3
$6.19M Sell
471,660
-15,557
-3% -$230K 0.05% 553
2022
Q2
$6.81M Sell
487,217
-11,194
-2% -$150K 0.05% 562
2022
Q1
$7.42M Sell
498,411
-7,252
-1% -$99.2K 0.04% 611
2021
Q4
$6.85M Buy
505,663
+7,079
+1% +$100K 0.03% 685
2021
Q3
$7.34M Sell
498,584
-3,171
-0.6% -$53.6K 0.04% 626
2021
Q2
$9.13K Sell
501,755
-26,910
-5% -$479K 0.03% 572
2021
Q1
$9.18K Buy
528,665
+5,046
+1% +$88.7K 0.03% 564
2020
Q4
$9.1K Buy
523,619
+26,655
+5% +$425K 0.03% 501
2020
Q3
$6.85M Sell
496,964
-10,071
-2% -$148K 0.03% 524
2020
Q2
$7.32M Sell
507,035
-9,362
-2% -$123K 0.04% 486
2020
Q1
$5.64M Buy
516,397
+24,657
+5% +$455K 0.03% 514
2019
Q4
$10.5M Buy
491,740
+11,921
+2% +$267K 0.04% 407
2019
Q3
$11M Buy
479,819
+18,205
+4% +$388K 0.04% 355
2019
Q2
$9.09M Sell
461,614
-4,432
-1% -$86.4K 0.04% 449
2019
Q1
$9.07M Sell
466,046
-11,285
-2% -$214K 0.03% 459
2018
Q4
$7.87M Buy
477,331
+79
+0% +$1.59K 0.03% 475
2018
Q3
$11M Buy
477,252
+5,814
+1% +$132K 0.04% 370
2018
Q2
$10.2M Buy
471,438
+5,152
+1% +$101K 0.04% 390
2018
Q1
$8.23M Sell
466,286
-18,322
-4% -$323K 0.03% 510
2017
Q4
$9.1M Buy
484,608
+18,172
+4% +$361K 0.03% 478
2017
Q3
$10.2M Buy
466,436
+418,043
+864% +$9.44M 0.04% 361
2017
Q2
$1.17M Buy
48,393
+8,616
+22% +$219K ﹤0.01% 1194
2017
Q1
$1.11M Sell
39,777
-7,680
-16% -$201K ﹤0.01% 1150
2016
Q4
$1.16M Sell
47,457
-706
-1% -$16.2K ﹤0.01% 1160
2016
Q3
$1.21M Sell
48,163
-31
-0.1% -$743 ﹤0.01% 1108
2016
Q2
$994K Sell
48,194
-386
-0.8% -$8.05K ﹤0.01% 1179
2016
Q1
$976K Buy
48,580
+5,136
+12% +$98.5K ﹤0.01% 1513
2015
Q4
$879K Buy
43,444
+513
+1% +$10.8K ﹤0.01% 1588
2015
Q3
$995K Buy
42,931
+274
+0.6% +$6.99K ﹤0.01% 1467
2015
Q2
$1.1M Buy
42,657
+1,043
+3% +$29.6K ﹤0.01% 1512
2015
Q1
$1.38M Buy
41,614
+848
+2% +$27.5K 0.01% 1396
2014
Q4
$1.24M Buy
40,766
+4,124
+11% +$114K 0.01% 1412
2014
Q3
$891K Buy
36,642
+555
+2% +$15.4K ﹤0.01% 1656
2014
Q2
$1.04M Buy
36,087
+6,049
+20% +$176K ﹤0.01% 1561
2014
Q1
$838K Buy
30,038
+1,607
+6% +$44.1K ﹤0.01% 1676
2013
Q4
$743K Buy
28,431
+209
+0.7% +$5.39K ﹤0.01% 1711
2013
Q3
$649K Sell
28,222
-493
-2% -$12.1K ﹤0.01% 1752
2013
Q2
$750K Buy
+28,715
New +$829K ﹤0.01% 1565

Other funds holding SBRA

American International Group's SBRA Position: Q2 2024 in Review

American International Group sold out of Sabra Healthcare REIT (SBRA) in Q2 2024, closing a stake of 418,331 shares — an estimated $6.18M sold.

American International Group first reported a position in SBRA in Q2 2013 and held it in 44 quarters. The position peaked at $11M in Q3 2018. 355 funds tracked by Wall St. Rank hold SBRA as of Q2 2024.

  • American International Group reported no remaining Sabra Healthcare REIT position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 418,331 Sabra Healthcare REIT shares in Q2 2024, an estimated $6.18M.
  • American International Group first reported a position in Sabra Healthcare REIT in Q2 2013 and held it in 44 quarters.
  • American International Group's Sabra Healthcare REIT position peaked at $11M in Q3 2018.
  • 355 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.